
ATUM is a life science company providing integrated bioengineering solutions that accelerate timelines from discovery to manufacturing, preclinical research to IND applications. Their business model includes gene design and synthesis, antibody services, cell line development, licensing, protein expression, cGMP cell banking, biological and protein engineering. They differentiate themselves with proprietary machine learning technology, such as GeneGPS, and a unique engineering platform based on Design of Experiment, empirical testing, and AI. ATUM supports a global customer base in academia, government, and industries including pharmaceuticals, chemical, agricultural, and biotechnology. The company emphasizes scientist-to-scientist collaboration and customer service, offering both products and services from their headquarters in Newark, California.

ATUM is a life science company providing integrated bioengineering solutions that accelerate timelines from discovery to manufacturing, preclinical research to IND applications. Their business model includes gene design and synthesis, antibody services, cell line development, licensing, protein expression, cGMP cell banking, biological and protein engineering. They differentiate themselves with proprietary machine learning technology, such as GeneGPS, and a unique engineering platform based on Design of Experiment, empirical testing, and AI. ATUM supports a global customer base in academia, government, and industries including pharmaceuticals, chemical, agricultural, and biotechnology. The company emphasizes scientist-to-scientist collaboration and customer service, offering both products and services from their headquarters in Newark, California.